CXCR4-Targeted Molecular Imaging in Hematology and Oncology
Journal of Nuclear Medicine · 2026-11 · 67 (11) · 1711-1718
DOI: 10.2967/jnumed.126.272587 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 13.08.2026. Verfasst von Rudolf A Werner und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; rudolf.werner@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Receptors, CXCR4, Molecular Imaging, Hematology, Medical Oncology. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
C-X-C motif chemokine receptor 4 (CXCR4) has emerged as a powerful imaging target in nuclear oncology. In this regard, the PET agent [68Ga]Ga-pentixafor is promising but still evolving. In this article, we provide an overview of potentially useful imaging applications for CXCR4-targeted imaging in hemato-oncology and guidance on scan interpretation by discussing diagnostic pitfalls. We also report on theranostic efforts and how the field has been expanded toward the imaging of solid tumors. As such, this review focuses on potential clinical integration of CXCR4-targeted molecular imaging across multiple disease entities, particularly in the field of hemato-oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; rudolf.werner@med.uni-muenchen.de.
- Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland.
- German Cancer Consortium, Partner Site Munich, a Partnership Between DKFZ and LMU University Hospital Munich, Munich, Germany.
- Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
- Department of Nuclear Medicine, University Hospital Vienna, Vienna, Austria.
- Department of Nuclear Medicine, Nantes Université, Université Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire, Nantes, France.
Zitieren
APA
Werner, R. A., Buck, A. K., Haug, A., Kraeber-Bodéré, F., Lapa, C., Schottelius, M., Serfling, S. E., Higuchi, T., Bodet-Milin, C., Raderer, M., Wegen, S., Pomper, M. G., Deroose, C. M., Herrmann, K., Keller, U., Kobe, C., & Gotthardt, M. (2026). CXCR4-Targeted Molecular Imaging in Hematology and Oncology. Journal of Nuclear Medicine, 67(11), 1711-1718. https://doi.org/10.2967/jnumed.126.272587
Vancouver
Werner RA, Buck AK, Haug A, Kraeber-Bodéré F, Lapa C, Schottelius M, et al. CXCR4-Targeted Molecular Imaging in Hematology and Oncology. Journal of Nuclear Medicine. 2026;67(11):1711-1718. doi:10.2967/jnumed.126.272587
BibTeX
@article{Werner2026,
author = {Werner, Rudolf A and Buck, Andreas K and Haug, Alexander and Kraeber-Bodéré, Francoise and Lapa, Constantin and Schottelius, Margret and Serfling, Sebastian E and Higuchi, Takahiro and Bodet-Milin, Caroline and Raderer, Markus and Wegen, Simone and Pomper, Martin G and Deroose, Christophe M and Herrmann, Ken and Keller, Ulrich and Kobe, Carsten and Gotthardt, Martin},
title = {CXCR4-Targeted Molecular Imaging in Hematology and Oncology},
journal = {Journal of Nuclear Medicine},
year = {2026},
volume = {67},
number = {11},
pages = {1711--1718},
doi = {10.2967/jnumed.126.272587}
}
EUVIMED